Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical results for N-3389 in emesis

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Delta-opioid receptor ligands reported by SmithKline Beecham

May 5, 1997

CoCensys and Novartis end stroke compound collaboration

May 2, 1997

Neurobiological Technologies initiates second phase II memantine trial

May 2, 1997

Modafinil for sleep apnea-hypopnea syndrome

May 2, 1997

Positive clinical results for pramipexole in schizophrenia

May 2, 1997

Antioxidants reported by Hoechst Marion Roussel

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

Guidant and Neuroperfusion to further develop device for stroke

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...